Evolution of locomotion disorders in Huntington's disease

被引:8
|
作者
Delval, A. [1 ]
Krystkowiak, P. [2 ]
Blatt, J. -L. [1 ]
Delliaux, M. [3 ]
Destee, A. [3 ]
Derambure, P. [1 ]
Defebvre, L. [3 ]
机构
[1] CHRU, Hop R Salengro, Serv Neurophysiol Clin, F-59037 Lille, France
[2] CHU Amiens, Hop Nord, Serv Neurol, F-80054 Amiens 1, France
[3] CHRU, Hop R Salengro, Serv Neurol & Pathol Mouvement, F-59037 Lille, France
来源
关键词
gait; gait initiation; anticipatory postural adjustments; Huntington's disease; decline;
D O I
10.1016/j.neucli.2008.01.003
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction. - Locomotion disorders are important in Huntington's disease (HD). Although the rates of evolution of motor, functional or cognitive aspects of HD have been studied, the evolution of locomotion disorders in early stages of the disease remains unknown. Objectives. - To determine the rate of evolution of the HD-associated gait and gait initiation disorders and their correlates. Patients and methods. - Eighteen HD patients were recorded with a minimum interevaluation interval of one year. Akinesia was studied by evaluating the anticipatory postural adjustment (APA) phase preceding the first step. We also evaluated gait speed, stride time and stride length. Results. - We observed an alteration in the APA phase, whose evolution was correlated with that of akinesia. We also observed a decrease in gait speed, which was due both to an increase in stride time and a decrease in stride length. Stride-to-stride variability did not worsen between both evaluations. Conclusions. - A worsening in both gait initiation and gait performance was observed in HD. Initial weak functional capacity and more severe motor impairment seem to be associated with a faster progression of locomotion parameters in these mildly impaired HD patients. (C) 2008 Elsevier Masson SAS. Tous droits reserves.
引用
收藏
页码:117 / 125
页数:9
相关论文
共 50 条
  • [41] Visual processing disorders in patients with Huntington's disease and asymptomatic carriers
    GomezTortosa, E
    delBarrio, A
    Barroso, T
    Ruiz, PJG
    JOURNAL OF NEUROLOGY, 1996, 243 (03) : 286 - 292
  • [42] Atypical onset movement disorders in Brazilian Huntington's disease patients
    Teive, H. A. G.
    Becker, N.
    Munhoz, R. P.
    Raskin, S.
    Werneck, L. C.
    MOVEMENT DISORDERS, 2007, 22 : S27 - S27
  • [44] Axonal transport failure in neurodegenerative disorders: the case of Huntington's disease
    Charrin, NC
    Saudou, F
    Humbert, S
    PATHOLOGIE BIOLOGIE, 2005, 53 (04): : 189 - 192
  • [45] Magnetization transfer MRI in dementia disorders, Huntington's disease and parkinsonism
    Tambasco, Nicola
    Nigro, Pasquale
    Romoli, Michele
    Simoni, Simone
    Parnetti, Lucilla
    Calabresi, Paolo
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 353 (1-2) : 1 - 8
  • [46] Effect of CAG repeat length on psychiatric disorders in Huntington's disease
    Vassos, Evangelos
    Panas, Marios
    Kladi, Athina
    Vassilopoulos, Dimitrios
    JOURNAL OF PSYCHIATRIC RESEARCH, 2008, 42 (07) : 544 - 549
  • [47] Modulation of Molecular Chaperones in Huntington's Disease and Other Polyglutamine Disorders
    Reis, Sara D.
    Pinho, Brigida R.
    Oliveira, Jorge M. A.
    MOLECULAR NEUROBIOLOGY, 2017, 54 (08) : 5829 - 5854
  • [48] Rhodiola rosea Improves Lifespan, Locomotion, and Neurodegeneration in a Drosophila melanogaster Model of Huntington's Disease
    Arabit, Jasmin G. J.
    Elhaj, Rami
    Schriner, Samuel E.
    Sevrioukov, Evgueni A.
    Jafari, Mahtab
    BIOMED RESEARCH INTERNATIONAL, 2018, 2018
  • [49] Rhodiola rosea improves lifespan, locomotion, and neurodegeneration in a Drosophila melanogaster model of Huntington's disease
    Arabit, J.
    Elhaj, R.
    Schriner, S. E.
    Sevrioukov, E. A.
    Jafari, M.
    PLANTA MEDICA, 2019, 85 (18) : 1415 - 1416
  • [50] Using Big Data in Movement Disorders: Disease States and Progression in Huntington's Disease
    Mestre, Tiago A.
    MOVEMENT DISORDERS, 2022, 37 (03) : 441 - 443